This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Brainstorm Cell Therapeutics Ltd.. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Alex Burshtein: Innovator in Stem Cell Research
Introduction
Alex Burshtein is a prominent inventor based in Rehovot, Israel. He has made significant contributions to the field of stem cell research, particularly in the generation of mesenchymal stem cells (MSCs) that secrete neurotrophic factors. His innovative methods have the potential to advance therapeutic applications in regenerative medicine.
Latest Patents
Alex Burshtein holds a patent for "Methods of generating mesenchymal stem cells which secrete neurotrophic factors." This patent describes a method of generating MSCs that secrete neurotrophic factors (NTFs) by incubating a population of undifferentiated MSCs in a differentiating medium that includes basic fibroblast growth factor (bFGF), platelet-derived growth factor (PDGF), heregulin, and cAMP. This groundbreaking work has implications for treating various neurological conditions.
Career Highlights
Alex Burshtein is associated with Brainstorm Cell Therapeutics Ltd., a company focused on developing innovative therapies for neurodegenerative diseases. His work at the company has positioned him as a key figure in the advancement of stem cell technologies.
Collaborations
Throughout his career, Alex has collaborated with notable colleagues, including Yael Gothelf and Yosef Levy. These partnerships have fostered a collaborative environment that enhances research and development in the field of stem cell therapy.
Conclusion
Alex Burshtein's contributions to stem cell research and his innovative patent highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in regenerative medicine and therapeutic applications.